SPHK1 and Miyoshi myopathy: The anti-cancer properties of FTY720 have not been explored in relation to MM, however, its molecular targets, SphK1 and PP2A are known to be involved in MM cell proliferation and survival [35–37], prompting us to investigate the possible anti-cancer activity of FTY720 in MM cells and in a syngeneic MM mouse model.